GLS2 and neoplasm: First, GLS2 can competitively bind to the small GTP enzyme Rac1 with guanine nucleotide exchange factor, an agonist of Rac1, and then inactivate Rac1, thus promoting P53-mediated tumour metastasis inhibition [27].